Senior Consultant Interventional Cardiologist, Department of Cardiology, Cardiac Consultant Hospital, Rajkot, Gujarat, India, Corresponding Author.
Consultant Interventional Cardiologist, Department of Cardiology, SMS Hospital, Jaipur, Rajasthan, India.
J Assoc Physicians India. 2024 Sep;72(9S):14-15. doi: 10.59556/japi.72.0670.
Loop diuretics, including torsemide, furosemide, bumetanide, and piretanide, act by inhibiting the sodium-potassium-chloride (Na/K/2Cl) cotransporter in the thick ascending limb of the loop of Henle within the nephron. This mechanism is pivotal in managing fluid retention associated with conditions such as heart failure, cirrhosis, chronic kidney disease, and hypertension. A comprehensive understanding of how these diuretics uniquely target this transporter provides crucial insights into effectively addressing fluid overload across diverse clinical conditions.
袢利尿剂,包括托塞米、呋塞米、布美他尼和吡嗪酰胺,通过抑制肾单位中的亨利袢升支粗段中的钠-钾-氯(Na/K/2Cl)共转运体来发挥作用。这种机制对于管理与心力衰竭、肝硬化、慢性肾脏病和高血压等疾病相关的液体潴留至关重要。全面了解这些利尿剂如何独特地靶向该转运体,为在各种临床情况下有效解决液体超负荷提供了重要的见解。